S -Adenosylmethionine (SAMe) in major depressive disorder (MDD): a clinician-oriented systematic rev...
S -Adenosylmethionine (SAMe) in major depressive disorder (MDD): a clinician-oriented systematic review
About this item
Full title
Author / Creator
Publisher
England: BioMed Central
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central
Subjects
More information
Scope and Contents
Contents
Major depressive disorder (MDD) is a recurrent illness with high rates of chronicity, treatment-resistance, and significant economic impact.
-Adenosylmethionine (SAMe), a molecule that is formed naturally in the human body, has shown antidepressant effects and may expand the available options for treating MDD. This systematic review examines the...
Alternative Titles
Full title
S -Adenosylmethionine (SAMe) in major depressive disorder (MDD): a clinician-oriented systematic review
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_3c3b882bb48348429fb05261049b7bbb
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3c3b882bb48348429fb05261049b7bbb
Other Identifiers
ISSN
1744-859X
E-ISSN
1744-859X
DOI
10.1186/s12991-020-00298-z
